Plain-English translation of NCT06593405 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Age-Related Macular Degeneration research guide →Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This study looks at whether occupational therapy — a type of hands-on therapy that helps people manage daily tasks — can make it easier for people with vision loss from AMD, diabetic retinopathy, or glaucoma to take their medications correctly. You would meet with a specially trained occupational therapist for one hour, who would teach you about devices and strategies to help you manage your medications despite your vision challenges.
Many people with vision loss don't know that occupational therapy can help them stay independent with important tasks like taking their medications on time and correctly. This study wants to find out if this treatment can really make a difference in helping patients manage their eye care.
You likely qualify if…
You likely don't qualify if…
You would attend one one-hour session with an occupational therapist, who would teach you strategies and devices to help with taking your medications. Before and after this session, you would complete two brief assessment questionnaires with the therapist's help. Then, four weeks later, you would meet with the therapist again (by phone or in person) to see how well the strategies are working and repeat the assessments so the therapist can measure whether the treatment helped.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
United States